Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where S. M. South is active.

Publication


Featured researches published by S. M. South.


Clinical and Experimental Pharmacology and Physiology | 2009

Antinociception versus serum concentration relationships following acute administration of intravenous morphine in male and female Sprague-dawley rats: Differences between the tail flick and hot plate nociceptive tests

S. M. South; Stephen R. Edwards; Maree T. Smith

1 Antinociception versus serum morphine concentration relationships were defined in male and female Sprague‐Dawley rats administered single intravenous (i.v.) bolus doses of morphine, using the hot plate (2.1–14 mg/kg) and tail flick tests (1–8 mg/kg). 2 Serum concentrations of morphine and morphine‐3‐glucuronide (M3G), its major metabolite in the rat, were assayed using high‐performance liquid chromatography (HPLC) with electrochemical detection. 3 Significantly higher (P < 0.05) values of peak antinociception (approximately 1.7‐fold), as well as the extent and duration of antinociception (approximately fourfold), were observed in male compared with female rats administered 10 mg/kg morphine in the hot plate test. Although there were no significant sex‐related differences in the area under the serum morphine concentration versus time curve (AUC) at this dose, systemic exposure to M3G (M3G AUC) was significantly higher (approximately twofold; P < 0.05) in female than male rats. 4 In contrast with most previous studies investigating sex differences in morphine antinociception in rats, the antinociceptive effects of single i.v. doses of morphine (1–8 mg/kg) in the tail flick test did not differ significantly between male and female rats. 5 Morphine ED50 and EC50 values (95% confidence intervals) for antinociception in the hot plate test were significantly lower (P < 0.05) in male rats (ED50 8.4 mg/kg (7.6–9.2); EC50 1.8 nmol/L (1.5–2.1)) compared with female rats (ED50 10.6 mg/kg (9.1–12.0); EC50 3.7 nmol/L (3.4–4.1)). However, in the tail flick test, there was no significant difference between male and female rats in ED50 (1.8 (0.4–3.3) and 1.4 mg/kg (0.4–2.5), respectively) or EC50 (0.5 (0.3–0.6) and 0.4 nmol/L (0.2–0.5), respectively) values. 6 Supraspinal attenuation of morphine antinociception by M3G may account for these differences.


Pain: Clinical Updates | 2001

Analgesic tolerance to opioids

S. M. South; Maree T. Smith


Journal of Pharmacology and Experimental Therapeutics | 2001

Sex-Related Differences in Antinociception and Tolerance Development following Chronic Intravenous Infusion of Morphine in the Rat: Modulatory Role of Testosterone via Morphine Clearance

S. M. South; A.W.E. Wright; Michael Lau; Laurence E. Mather; Maree T. Smith


Journal of Pharmacology and Experimental Therapeutics | 1998

Apparent Insensitivity of the Hotplate Latency Test for Detection of Antinociception Following Intraperitoneal, Intravenous or Intracerebroventricular M6G Administration to Rats

S. M. South; Maree T. Smith


Pain Reviews | 2001

The role of morphine-6-glucuronide (M6G) in pain control

Maree T. Smith; S. M. South


Archive | 2008

Pain pharmacology and analgesia

Maree T. Smith; S. M. South


28th Annual Scientific Meeting of the Australian Pain Society: The Spectrum of Pain | 2008

Influence of diet on the longitudinal temporal development of opioid hyposensitivity and tactile allodynia in the Zucker Diabetic Fatty (ZDF) rat

Kathleen J. Otto; Bruce D. Wyse; S. M. South; Peter J. Cabot; Maree T. Smith


12th World Congress on Pain | 2008

Comparative profiles of the antinociceptive and constipating effects of single intracerebroventricular (i.c.v.) bolus doses of morphine and oxycodone in rats

Andy Kuo; K. Hemstapat; Bruce D. Wyse; S. M. South; Maree T. Smith


Neuroscience | 2007

Possible mechanism of action for neuroprotective effect of fucoidin in A-beta-induced Alzheimer's disease model

A. Patel; S. M. South; Maree T. Smith; Peter J. Cabot


41st Annual Scientific Meeting of the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists and 10th Southeast Asian Western Pacific Regional Meeting of Pharmacologists | 2007

Additive Antinociception Following Co-administration of a NR2B-Selective NMDA Antagonist with BDNF

S. M. South; C. B. Dao; Bruce D. Wyse; Maree T. Smith

Collaboration


Dive into the S. M. South's collaboration.

Top Co-Authors

Avatar

Maree T. Smith

University of Queensland

View shared research outputs
Top Co-Authors

Avatar

Bruce D. Wyse

University of Queensland

View shared research outputs
Top Co-Authors

Avatar

Peter J. Cabot

University of Queensland

View shared research outputs
Top Co-Authors

Avatar

A.W.E. Wright

University of Queensland

View shared research outputs
Top Co-Authors

Avatar

Andy Kuo

University of Queensland

View shared research outputs
Top Co-Authors

Avatar

K. Hemstapat

University of Queensland

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge